• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纹状体是唐氏综合征中使用[C]匹兹堡化合物B(PiB)检测淀粉样蛋白负荷的早期准确指标:两种放射性示踪剂的比较。

The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: comparison of two radiotracers.

作者信息

McLachlan Max, Bettcher Brecca, McVea Andrew, DiFillipo Alexandra, Zammit Matthew, LeMerise Lisette, Rouanet Jeremy, Price Julie, Tudorascu Dana, Laymon Charles, Keator David, Lao Patrick, Brickman Adam M, Fryer Tim, Hartley Sigan, Ances Beau M, Johnson Sterling, Betthauser Tobey, Stone Charles K, Zaman Shahid, Handen Benjamin, Head Elizabeth, Mapstone Mark, Christian Bradley T

机构信息

University of Wisconsin-Madison, Madison, WI, USA.

University of California, Irvine, Irvine, CA, USA.

出版信息

medRxiv. 2024 Dec 6:2024.12.04.24318526. doi: 10.1101/2024.12.04.24318526.

DOI:10.1101/2024.12.04.24318526
PMID:39677434
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11643166/
Abstract

INTRODUCTION

Adults with Down syndrome demonstrate striatum-first amyloid accumulation with [C]PiB PET imaging, which has not been replicated with [F]florbetapir (FBP). Early striatal accumulation has not been temporally quantified with respect to global cortical measures.

METHODS

Longitudinal PiB (n=175 participants) and FBP (n=92 participants) data from the Alzheimer Biomarkers Consortium-Down Syndrome were used to measure cortical and striatal binding. Generalized temporal models for cortical and striatal amyloid accumulation were created using the sampled iterative local approximation (SILA) method.

RESULTS

PiB demonstrated greater striatal-to-cortical ratios than FBP. SILA analysis revealed striatal amyloid burden occurs 3.40 (2.39) years earlier than the cortex in PiB. There was no difference between the cortex and striatum in FBP.

DISCUSSION

Among adults with Down syndrome, the striatum consistently accumulates amyloid earlier than the cortex when measured with PiB. This suggests the striatum is more sensitive to the onset of PiB PET-detectable amyloid in Down syndrome.

摘要

引言

唐氏综合征成年人在[C]匹兹堡化合物B(PiB)正电子发射断层扫描(PET)成像中显示纹状体先于淀粉样蛋白积累,而[F]氟代硼替佐米(FBP)尚未复制这一现象。早期纹状体积累尚未相对于全脑皮质测量进行时间量化。

方法

来自阿尔茨海默病生物标志物联盟 - 唐氏综合征的纵向PiB(n = 175名参与者)和FBP(n = 92名参与者)数据用于测量皮质和纹状体结合。使用采样迭代局部近似(SILA)方法创建皮质和纹状体淀粉样蛋白积累的广义时间模型。

结果

PiB显示出比FBP更高的纹状体与皮质比值。SILA分析显示,在PiB中,纹状体淀粉样蛋白负担比皮质早3.40(2.39)年出现。FBP中皮质和纹状体之间没有差异。

讨论

在唐氏综合征成年人中,用PiB测量时,纹状体始终比皮质更早积累淀粉样蛋白。这表明纹状体对唐氏综合征中PiB PET可检测淀粉样蛋白的发病更敏感。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/52b855dfade0/nihpp-2024.12.04.24318526v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/246b068481b9/nihpp-2024.12.04.24318526v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/ae644e850c5d/nihpp-2024.12.04.24318526v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/9ec603d85cce/nihpp-2024.12.04.24318526v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/712db69707f9/nihpp-2024.12.04.24318526v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/5f85c70ec196/nihpp-2024.12.04.24318526v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/52b855dfade0/nihpp-2024.12.04.24318526v1-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/246b068481b9/nihpp-2024.12.04.24318526v1-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/ae644e850c5d/nihpp-2024.12.04.24318526v1-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/9ec603d85cce/nihpp-2024.12.04.24318526v1-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/712db69707f9/nihpp-2024.12.04.24318526v1-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/5f85c70ec196/nihpp-2024.12.04.24318526v1-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/65a9/11643166/52b855dfade0/nihpp-2024.12.04.24318526v1-f0006.jpg

相似文献

1
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: comparison of two radiotracers.纹状体是唐氏综合征中使用[C]匹兹堡化合物B(PiB)检测淀粉样蛋白负荷的早期准确指标:两种放射性示踪剂的比较。
medRxiv. 2024 Dec 6:2024.12.04.24318526. doi: 10.1101/2024.12.04.24318526.
2
The striatum is an early, accurate indicator of amyloid burden using [C]PiB in Down syndrome: Comparison of two radiotracers.在唐氏综合征中,纹状体是使用[C]PiB检测淀粉样蛋白负荷的早期、准确指标:两种放射性示踪剂的比较。
Alzheimers Dement. 2025 Apr;21(4):e70141. doi: 10.1002/alz.70141.
3
Longitudinal head-to-head comparison of C-PiB and F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.在一项针对显性遗传性阿尔茨海默病的抗淀粉样蛋白β单克隆抗体的 2/3 期临床试验中,进行 C-PiB 和 F-氟比他滨 PET 的纵向对头比较。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.
4
A head-to-head comparison of multiple amyloid PET radiotracers for Down syndrome clinical trials.用于唐氏综合征临床试验的多种淀粉样蛋白PET放射性示踪剂的直接比较。
medRxiv. 2025 Mar 19:2025.03.18.25324200. doi: 10.1101/2025.03.18.25324200.
5
Harmonizing florbetapir and PiB PET measurements of cortical Aβ plaque burden using multiple regions-of-interest and machine learning techniques: An alternative to the Centiloid approach.利用多感兴趣区和机器学习技术协调 florbetapir 和 PiB PET 测量的皮质 Aβ斑块负担:替代 Centiloid 方法。
Alzheimers Dement. 2024 Mar;20(3):2165-2172. doi: 10.1002/alz.13677. Epub 2024 Jan 26.
6
Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease.纹状体淀粉样蛋白与家族性阿尔茨海默病中的 tau 病和记忆下降有关。
Alzheimers Res Ther. 2019 Feb 4;11(1):17. doi: 10.1186/s13195-019-0468-1.
7
The correlation between striatal and cortical binding ratio of C-PiB-PET in amyloid-uptake-positive patients.淀粉样蛋白摄取阳性患者中C-PiB-PET纹状体与皮质结合率之间的相关性。
Ann Nucl Med. 2018 Jul;32(6):398-403. doi: 10.1007/s12149-018-1258-8. Epub 2018 May 5.
8
The diagnostic performance of [F]Florbetazine in Alzheimer's disease: a head-to-head comparison to [C]PiB and [F]Florbetapir.[F]氟贝他嗪在阿尔茨海默病中的诊断性能:与[C]匹兹堡化合物B(PiB)和[F]氟代硼替佐米(Florbetapir)的直接比较。
Eur J Nucl Med Mol Imaging. 2025 Apr 4. doi: 10.1007/s00259-025-07233-y.
9
Amyloid PET imaging in Alzheimer's disease: a comparison of three radiotracers.阿尔茨海默病的淀粉样蛋白 PET 成像:三种放射性示踪剂的比较。
Eur J Nucl Med Mol Imaging. 2014 Jul;41(7):1398-407. doi: 10.1007/s00259-014-2753-3. Epub 2014 Mar 20.
10
PET measurement of longitudinal amyloid load identifies the earliest stages of amyloid-beta accumulation during Alzheimer's disease progression in Down syndrome.PET 测量纵向淀粉样蛋白负荷可在唐氏综合征阿尔茨海默病进展过程中识别淀粉样β 聚集的最早阶段。
Neuroimage. 2021 Mar;228:117728. doi: 10.1016/j.neuroimage.2021.117728. Epub 2021 Jan 7.

本文引用的文献

1
Alzheimer's drugs, APPlication for Down syndrome?治疗阿尔茨海默病的药物,能否应用于唐氏综合征?
Ageing Res Rev. 2024 Apr;96:102281. doi: 10.1016/j.arr.2024.102281. Epub 2024 Mar 19.
2
Adapting prescribing criteria for amyloid-targeted antibodies for adults with Down syndrome.为唐氏综合征成人患者调整淀粉样蛋白靶向抗体的处方标准。
Alzheimers Dement. 2024 May;20(5):3649-3656. doi: 10.1002/alz.13778. Epub 2024 Mar 13.
3
Down Syndrome in a New Era for Alzheimer Disease.唐氏综合征在阿尔茨海默病的新时代
JAMA. 2023 Dec 12;330(22):2157-2158. doi: 10.1001/jama.2023.22924.
4
Characterizing the emergence of amyloid and tau burden in Down syndrome.描述唐氏综合征中淀粉样蛋白和tau 负担的出现。
Alzheimers Dement. 2024 Jan;20(1):388-398. doi: 10.1002/alz.13444. Epub 2023 Aug 29.
5
Donanemab in Early Symptomatic Alzheimer Disease: The TRAILBLAZER-ALZ 2 Randomized Clinical Trial.多奈哌齐治疗早期症状性阿尔茨海默病的随机临床试验。
JAMA. 2023 Aug 8;330(6):512-527. doi: 10.1001/jama.2023.13239.
6
Anti-Amyloid Monoclonal Antibodies are Transformative Treatments that Redefine Alzheimer's Disease Therapeutics.抗淀粉样蛋白单克隆抗体是具有变革性的治疗方法,重新定义了阿尔茨海默病的治疗方法。
Drugs. 2023 May;83(7):569-576. doi: 10.1007/s40265-023-01858-9. Epub 2023 Apr 15.
7
Longitudinal head-to-head comparison of C-PiB and F-florbetapir PET in a Phase 2/3 clinical trial of anti-amyloid-β monoclonal antibodies in dominantly inherited Alzheimer's disease.在一项针对显性遗传性阿尔茨海默病的抗淀粉样蛋白β单克隆抗体的 2/3 期临床试验中,进行 C-PiB 和 F-氟比他滨 PET 的纵向对头比较。
Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2669-2682. doi: 10.1007/s00259-023-06209-0. Epub 2023 Apr 5.
8
Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study.唐氏综合征与常染色体显性阿尔茨海默病患者淀粉样蛋白负担的比较:一项横断面研究。
Lancet Neurol. 2023 Jan;22(1):55-65. doi: 10.1016/S1474-4422(22)00408-2.
9
Lecanemab in Early Alzheimer's Disease.早期阿尔茨海默病中的lecanemab
N Engl J Med. 2023 Jan 5;388(1):9-21. doi: 10.1056/NEJMoa2212948. Epub 2022 Nov 29.
10
Vascular Considerations for Amyloid Immunotherapy.血管因素在淀粉样变免疫治疗中的考虑。
Curr Neurol Neurosci Rep. 2022 Nov;22(11):709-719. doi: 10.1007/s11910-022-01235-1. Epub 2022 Oct 21.